Badgley Phelps Wealth Managers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Sell
122,271
-21
-0% -$2.94K 0.34% 81
2025
Q4
$15M Hold
122,292
0.27% 88
2025
Q3
$13.6M Sell
122,292
-55
-0% -$6.25K 0.29% 88
2025
Q2
$13.6M Sell
122,347
-309
-0.3% -$32.9K 0.3% 88
2025
Q1
$13.7M Buy
122,656
+328
+0.3% +$33.8K 0.33% 84
2024
Q4
$11.3M Sell
122,328
-1,300
-1% -$117K 0.26% 100
2024
Q3
$10.4M Sell
123,628
-96
-0.1% -$7.33K 0.24% 102
2024
Q2
$8.49M Sell
123,724
-15
-0% -$1K 0.21% 106
2024
Q1
$9.06M Sell
123,739
-127
-0.1% -$9.77K 0.23% 105
2023
Q4
$10M Buy
123,866
+35,933
+41% +$2.8M 0.27% 97
2023
Q3
$6.59M Sell
87,933
-567
-0.6% -$43.6K 0.22% 102
2023
Q2
$6.82M Sell
88,500
-143
-0.2% -$11.4K 0.23% 104
2023
Q1
$7.35M Sell
88,643
-2,577
-3% -$213K 0.27% 103
2022
Q4
$7.83M Sell
91,220
-1,250
-1% -$99K 0.31% 96
2022
Q3
$5.71M Hold
92,470
0.24% 100
2022
Q2
$5.72M Sell
92,470
-819
-0.9% -$50.7K 0.23% 101
2022
Q1
$5.55M Buy
93,289
+10
+0% +$639 0.19% 106
2021
Q4
$6.77M Buy
93,279
+164
+0.2% +$11.3K 0.22% 108
2021
Q3
$6.5M Buy
+93,115
New +$6.54M 0.24% 105

Other funds holding GILD

Badgley Phelps Wealth Managers's GILD Position: Q1 2026 in Review

Badgley Phelps Wealth Managers reduced its Gilead Sciences (GILD) stake by 0.02% in Q1 2026, selling an estimated $2.94K and leaving 122,271 shares worth $17M. The position accounts for 0.34% of the portfolio, ranked #81.

Badgley Phelps Wealth Managers first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Badgley Phelps Wealth Managers held 122,271 shares of Gilead Sciences worth $17M as of Q1 2026.
  • Badgley Phelps Wealth Managers sold 21 Gilead Sciences shares in Q1 2026, an estimated $2.94K.
  • Gilead Sciences made up 0.34% of Badgley Phelps Wealth Managers's portfolio in Q1 2026, its #81 holding.
  • Badgley Phelps Wealth Managers first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Badgley Phelps Wealth Managers's 13F filing for Q1 2026, filed 15 Apr 2026.